查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
横向流动分析市场-全球行业规模、份额、趋势、机会和预测，2018-2028 年，按产品类型、应用、技术、测试类型、最终用户、地区、竞争
市场调查报告书
商品编码
1255230

横向流动分析市场-全球行业规模、份额、趋势、机会和预测，2018-2028 年，按产品类型、应用、技术、测试类型、最终用户、地区、竞争

Lateral Flow Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product, By Application, By Technique, By Test Type, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 116 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球侧流分析市场预计在预测期内将出现显着增长。

这是由于结核病、肝炎和流感等传染病日益流行，以及对即时检测的需求不断增加。 同样，在预测期内，越来越多地采用横向流动分析试剂盒等新技术也有望带来显着增长。 此外，人口老龄化日益加剧，更容易患上各类慢性病，增加了对家庭检测方法的需求。 预计这将在预测期内推动市场增长。 此外，提高公众对新测试分析的认识也将推动市场增长到 2028 年。 在 2019-2020 流感季节，美国发生了 3600 万例流感病例。 2019-2020 流感季节有 20,342 人死于流感。 在 2019-2020 年流感季节，流感导致的死亡大多数发生在 65 岁及以上的人群中。

传染病传播

由于慢性病的生理变化、代谢问题和免疫系统减弱，囊性纤维化、心血管疾病、肝炎和癌症等慢性病正在迅速增加，预计这将在预测期内推动市场增长。 同样，改变健康的生活方式将推动各地区疾病的增加，预计这将在预测期内推动市场增长。 2020年9月，Qiagen N.V.收购了NeuMoDx Molecular, Inc.，扩大了Qiagen的诊断产品线，提升了其在自动化分子检测领域的市场地位。 这扩大了 QIAGEN 提供的自动化测试解决方案的范围，并为未来的增长提供了新的催化剂。 政府对使用新检测方法的举措和意识将在预测期内推动市场增长。 2021 年，美国 50 个州和哥伦比亚特区 (DC) 向 CDC 国家结核病监测系统 (NTSS) 初步报告了 7,860 例结核病病例。 由于不健康的食品消费导致艾滋病毒和疟疾等传染病日益流行，预计在预测期内将产生有利可图的增长。 慢性病患病率的增加将增加对健康生活方式的需求，预计这将进一步推动市场增长。 2001 年全世界约 46% 的所有疾病和 5650 万人死亡中的 60% 是由慢性病引起的。

对可以在家完成的测试方法的需求增加

用于慢性病检测、妊娠检测、生育力检测、凝血检测、尿液化学等的家庭检测试剂盒的需求不断增长，以及对即时检测的需求不断增长，将进一步推动对侧流检测的需求。,该设备使用量的快速增长可能会在预测期内进一步推动市场增长。 根据 Statista 的数据，2020 年美国有 792 万女性使用了家庭妊娠试验。 领先的公司专注于开发创新的基于横向流动检测的即时检测设备，用于使用 HCG 水平和排卵进行妊娠检测、传染病广告药物护理和促进等应用。蛋白质标记物的测量有望加强对侧流分析市场多年。 例如，2019年，美国Abbott公司开发了血液检测“ARCHITECT stat Troponin I”，Siemens公司开发了用于临床诊断的“CLINITEK Microalbumin 2 strips”。

近期发展

专业临床诊断产品製造商 Novasito 宣布将推出 PathFlow COVID-19 抗原侧流检测 (LFT)，以加强其 COVID-19 产品组合併寻求新的市场机会，尤其是在床旁 ( POC）环境，我们将发布2个产品。 2020年9月，瑞士F. Hoffmann-La Roche, Ltd.推出SARS-CoV-2抗原快速检测试剂盒和SARS-CoV-2抗体快速检测试剂盒。

可自定义

根据市场数据，TechSci Research 根据公司的具体需求提供定制服务。 该报告可以定制为：

公司信息

  • 对其他市场参与者（最多 5 家）进行深入分析和概况分析。

内容

第 1 章概述

  • 市场定义
  • 市场范围
    • 目标市场
    • 研究目标年份
    • 主要市场细分

第二章研究方法论

  • 调查目的
  • 基线调查方法
  • 主要行业合作伙伴
  • 主要协会和次要信息
  • 调查方法
  • 数据三角测量和验证
  • 假设和限制

第 3 章执行摘要

  • 市场概览
  • 主要市场细分概述
  • 主要市场参与者概览
  • 主要地区/国家概览
  • 市场驱动因素、挑战和趋势概述

第 4 章 VOC（客户之声）

第 5 章侧流分析的全球市场展望

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按产品（试剂盒/试剂、横向流动阅读器、其他）
    • 按应用（临床测试、心臟标誌物测试、妊娠/生育力测试、兽医诊断等）
    • 按方法（夹心试验、竞争性试验、多重检测试验）
    • 按测试类型（侧流免疫分析/核酸侧流分析）
    • 由最终用户（医院/诊所、诊断机构等）
    • 按地区
    • 按公司分类（2022 年）
  • 市场地图
    • 按产品分类
    • 通过申请
    • 按技术
    • 按测试类型
    • 最终用户
    • 按地区

第 6 章北美侧流分析的市场展望

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按产品（试剂盒/试剂、横向流动阅读器、其他）
    • 按应用（临床测试、心臟标誌物测试、妊娠/生育力测试、兽医诊断等）
    • 按方法（夹心试验、竞争性试验、多重检测试验）
    • 按测试类型（侧流免疫分析/核酸）
    • 由最终用户（医院/诊所、诊断机构等）
    • 按国家
  • 北美：国家/地区分析
    • 美国
    • 墨西哥
    • 加拿大

第 7 章：欧洲侧流分析市场展望

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按产品（试剂盒/试剂、横向流动阅读器、其他）
    • 按应用（临床测试、心臟标誌物测试、妊娠/生育力测试、兽医诊断等）
    • 按方法（夹心试验、竞争性试验、多重检测试验）
    • 按测试类型（侧流免疫分析/核酸）
    • 由最终用户（医院/诊所、诊断机构等）
    • 按国家
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第 8 章亚太侧流分析市场展望

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按产品（试剂盒/试剂、横向流动阅读器、其他）
    • 按应用（临床测试、心臟标誌物测试、妊娠/生育力测试、兽医诊断等）
    • 按方法（夹心试验、竞争性试验、多重检测试验）
    • 按测试类型（侧流免疫分析/核酸）
    • 由最终用户（医院/诊所、诊断机构等）
    • 按国家
  • 亚太地区：国家/地区分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚

第 9 章南美横向流动分析市场展望

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按产品（试剂盒/试剂、横向流动阅读器、其他）
    • 按应用（临床测试、心臟标誌物测试、妊娠/生育力测试、兽医诊断等）
    • 按方法（夹心试验、竞争性试验、多重检测试验）
    • 按测试类型（侧流免疫分析/核酸）
    • 由最终用户（医院/诊所、诊断机构等）
    • 按国家
  • 南美洲：：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章中东和非洲侧流分析市场展望

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按产品（试剂盒/试剂、横向流动阅读器、其他）
    • 按应用（临床测试、心臟标誌物测试、妊娠/生育力测试、兽医诊断等）
    • 按方法（夹心试验、竞争性试验、多重检测试验）
    • 按测试类型（侧流免疫分析/核酸侧流分析）
    • 由最终用户（医院/诊所、诊断机构等）
    • 按国家
  • MEA：国家分析
    • 南非侧流分析
    • 沙特阿拉伯侧流分析
    • 阿联酋侧流分析

第 11 章市场动态

  • 司机
  • 任务

第12章市场趋势与发展

  • 近期趋势
  • 併购
  • 产品发布

第 13 章侧流分析的全球市场：SWOT 分析

第 14 章波特的五力分析

  • 行业竞争
  • 新进入的可能性
  • 供应商的力量
  • 客户力量
  • 替代品的威胁

第第十五章竞争格局

  • 业务概览
  • 产品供应
  • 最近的发展
  • 财务（据报导）
  • 主要人员
  • SWOT 分析
    • Thermo Fisher Scientific, Inc.
    • Abbott Laboratories, Inc.
    • F. Hoffmann-La Roche AG
    • Bio-Rad Laboratories, Inc.
    • Quidel Corporation
    • Hologic, Inc.
    • bioMerieux SA
    • PerkinElmer, Inc.
    • Danaher Corporation
    • QIAGEN N.V.

第 16 章战略建议

简介目录
Product Code: 14323

The Global Lateral Flow Assay Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing prevalence of infectious diseases such as TB, Hepatitis, and Influenza STI, along with the growing demand for point-of-care testing. Similarly, the growing adoption of new technology like lateral flow assay kits is expected to create significant growth during the forecast period. Additionally, growing geriatric populations are susceptible to different types of chronic diseases, which enhances the demand for home-based testing methods. This, in turn, is expected to boost market growth during the forecast period. Besides, growing public awareness about the new testing assay is also propelling market growth through 2028. , during the 2019-2020 flu season, there were 36 million cases of influenza in the United States. The number of influenza deaths during the 2019-2020 flu season was 20,342. The vast majority of deaths attributed to influenza during the 2019-2020 flu season occurred among those aged 65 years and older.

Growing prevalence of infectious diseases

Chronic illnesses such as cystic fibrosis, cardiovascular diseases, hepatitis, and cancer are rapidly increasing due to physiological changes, metabolic problems, and low immune systems, and so the aging population is prone to these types of chronic diseases, which will enhance the growth of the market during the forecast period. Similarly, changing a healthy lifestyle will enhance disease growth across the region, and this, in turn, will boost the market growth during the forecast period. In September 2020, Qiagen N.V. bought NeuMoDx Molecular, Inc. to expand Qiagen's diagnostics instrument product line and boost its market position in automated molecular testing. This will broaden QIAGEN's offering of automated testing solutions and serve as another catalyst for future growth. Government initiative and awareness about using new assays will boost the market growth during the forecast period. During 2021, a total of 7,860 TB cases were provisionally reported to CDC's National Tuberculosis Surveillance System (NTSS) by the 50 U.S. states and the District of Columbia (DC). The increasing prevalence of infectious diseases like HIV and malaria due to consuming unhealthy food is expected to create lucrative growth during the forecast period. Due to the increasing prevalence of chronic diseases, demand leading a healthy lifestyle increased, which is further expected to drive the growth of the market over the years. Around 46% of all diseases worldwide and 60% of the 56.5 million deaths in 2001 were due to chronic conditions.

Increasing demand for home-based testing method

Rising demand for home-based testing kits for the detection of chronic diseases, pregnancy tests, fertility tests, coagulation tests, urine chemistry, etc., the growing demand for point-of-care testing may further enhance the demand for lateral flow assay, and usage of this device is rapidly increased which may further propel the growth of the market during the forecast period. According to this Statista, 7.92 million women in the U.S. used home pregnancy tests in 2020. Major companies are focusing on developing innovative lateral flow assay-based point-of-care devices for applications such as pregnancy tests by using HCG levels and ovulation, careening for infectious diseases ad drugs, and the measurement of protein markers in the boost is expected to enhance the demand for lateral flow assay market over the years. For instance, in 2019, Abbott Laboratories (US) developed its ARCHITECT stat Troponin I blood test, while Siemens AG developed the CLINITEK Microalbumin 2 strips for clinical diagnostics.

Market Segmentation

The global lateral flow assay market can be segmented by product, application, technique, test type, end-user, and by region. Based on the product, the market can be segmented into Kits & Reagents, Lateral Flow Readers, and Others. Based on application, the market can be segmented into Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, and Others. Based on technique, the market can be differentiated by Sandwich Assay, Competitive Assay, and Multiplex Detection Assay. Based on test type, the market can be divided into Lateral Flow Immunoassay and Nucleic Acid Lateral Flow Assay. Based on end-user, the market can be differentiated into Hospitals & Clinics, Diagnostic Laboratories, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, the Middle East & Africa, and South America. Among different countries, the United States dominates the global lateral flow assay market on account of the growing prevalence of infectious diseases and the demand for new technology with affordable costs in the country. Reported TB incidence (cases per 100,000 persons) increased by 9.4%, from 2.2 in 2020 to 2.4 in 2021 but was lower than incidence during 2019 (2.7). Increases occurred among both U.S.-born and non-U.S.-born persons.

Market Players

Thermo Fisher Scientific, Inc., Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Quidel Corporation, Hologic, Inc., bioMerieux SA, PerkinElmer, Inc., Danaher Corporation, QIAGEN N.V. are some of the leading players operating in the Global Lateral Flow Assay Market.

Recent Developments

Novacyt, a specialist in clinical diagnostics, is to launch two PathFlow COVID-19 antigen lateral flow tests (LFTs) to strengthen its COVID-19 portfolio and to pursue new market opportunities, especially in point-of-care (POC) settings. In September 2020, F. Hoffmann-La Roche AG (Switzerland) launched a SARS-CoV-2 rapid antigen test kit and a SARS-CoV-2 rapid antibody test kit.

Report Scope

In this report, the global lateral flow assay market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Lateral Flow Assay Market, By Product:

  • Kits & Reagents
  • Lateral Flow Readers
  • Others

Lateral Flow Assay Market, By Application:

  • Clinical Testing
  • Cardiac Marker Testing
  • Pregnancy & Fertility Testing
  • Veterinary Diagnostics
  • Others

Lateral Flow Assay Market, By Technique:

  • Sandwich Assay
  • Competitive Assay
  • Multiplex Detection Assay

Lateral Flow Assay Market, By Test Type:

  • Lateral Flow Immunoassay
  • Nucleic Acid Lateral Flow Assay

Lateral Flow Assay Market, By End User:

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Others

Lateral Flow Assay Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Lateral Flow Assay Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Lateral Flow Assay Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
    • 5.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
      • 5.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
      • 5.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
      • 5.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
    • 5.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
    • 5.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
    • 5.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
    • 5.2.6. By Region
    • 5.2.7. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Product
    • 5.3.2. By Application
    • 5.3.3. By Technique
    • 5.3.4. By Test Type
    • 5.3.5. By End User
    • 5.3.6. By Region

6. North America Lateral Flow Assay Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
    • 6.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
      • 6.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
      • 6.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
      • 6.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
    • 6.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
    • 6.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
    • 6.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Lateral Flow Assay Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Technique
        • 6.3.1.2.4. By Test Type
        • 6.3.1.2.5. By End User
    • 6.3.2. Mexico Lateral Flow Assay Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Technique
        • 6.3.2.2.4. By Test Type
        • 6.3.2.2.5. By End User
    • 6.3.3. Canada Lateral Flow Assay Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Technique
        • 6.3.3.2.4. By Test Type
        • 6.3.3.2.5. By End User

7. Europe Lateral Flow Assay Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
    • 7.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
      • 7.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
      • 7.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
      • 7.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
    • 7.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
    • 7.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
    • 7.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Lateral Flow Assay Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Technique
        • 7.3.1.2.4. By Test Type
        • 7.3.1.2.5. By End User
    • 7.3.2. Germany Lateral Flow Assay Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Technique
        • 7.3.2.2.4. By Test Type
        • 7.3.2.2.5. By End User
    • 7.3.3. United Kingdom Lateral Flow Assay Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Technique
        • 7.3.3.2.4. By Test Type
        • 7.3.3.2.5. By End User
    • 7.3.4. Italy Lateral Flow Assay Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Technique
        • 7.3.4.2.4. By Test Type
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Lateral Flow Assay Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Technique
        • 7.3.5.2.4. By Test Type
        • 7.3.5.2.5. By End User

8. Asia-Pacific Lateral Flow Assay Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
    • 8.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
      • 8.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
      • 8.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
      • 8.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
    • 8.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
    • 8.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
    • 8.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
    • 8.2.6. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Lateral Flow Assay Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Technique
        • 8.3.1.2.4. By Test Type
        • 8.3.1.2.5. By End User
    • 8.3.2. India Lateral Flow Assay Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Technique
        • 8.3.2.2.4. By Test Type
        • 8.3.2.2.5. By End User
    • 8.3.3. South Korea Lateral Flow Assay Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Technique
        • 8.3.3.2.4. By Test Type
        • 8.3.3.2.5. By End User
    • 8.3.4. Japan Lateral Flow Assay Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Technique
        • 8.3.4.2.4. By Test Type
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Lateral Flow Assay Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Technique
        • 8.3.5.2.4. By Test Type
        • 8.3.5.2.5. By End User

9. South America Lateral Flow Assay Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
    • 9.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
      • 9.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
      • 9.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
      • 9.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
    • 9.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
    • 9.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
    • 9.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
    • 9.2.6. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Lateral Flow Assay Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Technique
        • 9.3.1.2.4. By Test Type
        • 9.3.1.2.5. By End User
    • 9.3.2. Argentina Lateral Flow Assay Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Technique
        • 9.3.2.2.4. By Test Type
        • 9.3.2.2.5. By End User
    • 9.3.3. Colombia Lateral Flow Assay Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Technique
        • 9.3.3.2.4. By Test Type
        • 9.3.3.2.5. By End User

10. Middle East and Africa Lateral Flow Assay Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
    • 10.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
      • 10.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
      • 10.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
      • 10.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
    • 10.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
    • 10.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
    • 10.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
    • 10.2.6. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Lateral Flow Assay Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Technique
        • 10.3.1.2.4. By Test Type
        • 10.3.1.2.5. By End User
    • 10.3.2. Saudi Arabia Lateral Flow Assay Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Technique
        • 10.3.2.2.4. By Test Type
        • 10.3.2.2.5. By End User
    • 10.3.3. UAE Lateral Flow Assay Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Technique
        • 10.3.3.2.4. By Test Type
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Lateral Flow Assay Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1 Thermo Fisher Scientific, Inc.
    • 15.6.2 Abbott Laboratories, Inc.
    • 15.6.3 F. Hoffmann-La Roche AG
    • 15.6.4 Bio-Rad Laboratories, Inc.
    • 15.6.5 Quidel Corporation
    • 15.6.6 Hologic, Inc.
    • 15.6.7 bioMerieux SA
    • 15.6.8 PerkinElmer, Inc.
    • 15.6.9 Danaher Corporation
    • 15.6.10 QIAGEN N.V.

16. Strategic Recommendations